HOME >> BIOLOGY >> NEWS
Vision: how perceptions survive in the face of ambiguity

ented image stemmed from each eye being presented with a different image. In this test, two different patterns were intermittently presented separately to the two eyes and were swapped between the two eyes synchronously with the intermittent presentation. The researchers found that perceptual stablization did not appear to be based on the memory or representation of the stimulus itself; instead, it was based on perception being stabilized to one eye rather than the other.

Together, the findings from both experiments are consistent with the view that the possible mechanism underlying perceptual stabilization is not the memory of a stimulus, but rather the removal of so-called local adaptation.


'"/>

Contact: Heidi Hardman
hhardman@cell.com
617-397-2879
Cell Press
7-Jun-2004


Page: 1 2

Related biology news :

1. New physical activity opinion survey demonstrates perceptions do not meet reality
2. New discovery may help transplants survive
3. Chipmunks descended from ancestors that survived last ice age, scientists say
4. Helping coral reefs survive climate change
5. Mechanism that enables fetus to survive in mother under study
6. Common microbes survive pressures equal to those found at 50 kilometers inside the Earths crust
7. Rock-eating microbes survive in deep ocean off Peru
8. Hitchhiking molecules could have survived fiery comet collisions with Earth, UC Berkeley experiment shows
9. Helping energy conservation projects survive the budget axe
10. Deadly to cattle and humans, prions may help other organisms survive, researchers find
11. Life in the inferno: researchers identify factors that determine where microorganisms can survive in the hellish world deep underground

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Vision how perceptions survive the face ambiguity

(Date:4/17/2014)... trials to treat tuberculosis could be the basis for ... bacteria, fungal infections and parasites, yet evade resistance, according ... collaborators. , Led by U. of I. chemistry professor ... drug SQ109 attacks the tuberculosis bacterium, how the drug ... to malaria and how targeting multiple pathways reduces ...
(Date:4/17/2014)... word for chili peppers. Information about archaeological remains of ... of the appearance of words for chili peppers in ... domesticated and highlight the value of multi-proxy data analysis. ... of nine papers presented in a special feature issue ... Sciences on plant and animal domestication edited by ...
(Date:4/17/2014)... West Orange, NJ. April 16, 2014. Kessler Foundation ... for $1.8 million from the Department of Defense ... PhD, is principal investigator for the randomized, double-blinded, ... to improve bone and muscle strength after spinal ... Human Performance & Engineering Research at Kessler Foundation. ...
Breaking Biology News(10 mins):Multitarget TB drug could treat other diseases, evade resistance 2Chickens to chili peppers 2Chickens to chili peppers 3Kessler Foundation awarded Department of Defense grant for spinal cord injury research 2
(Date:1/15/2014)... , Jan. 15, 2014 TaiGen Biotechnology Company, ... exclusive agreement with R-Pharm, a leading Russian pharmaceutical company, ... the Russian Federation , ... Independent States (CIS). Nemonoxacin is a novel antibiotic for the ...
(Date:1/14/2014)... 2014 Histogen, Inc., a regenerative medicine ... grown under simulated embryonic conditions, today announced that they ... Medical, Inc. for physician-dispensed aesthetic products containing Histogen’s proprietary ... agreement is an amendment to the existing license between ...
(Date:1/14/2014)... York, NY (PRWEB) January 14, 2014 ... of Alliqua, Inc. (OTCQB: ALQA). Alliqua is an emerging ... to serve the wound care market. , Free report ... was restructured with a seasoned management team and Board, ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 iLab Solutions, the ... as the new Director of Product Strategy. In this role, ... as iLab sub-teams to guide in the development of iLab ... provides the maximum possible benefit to the scientific community by ...
Breaking Biology Technology:TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2
Cached News: